In Unreliable: Bias, Fraud, and the Reproducibility Crisis in Biomedical Research, published next week by Columbia University ...
The time of day of immunotherapy infusions does appear to affect patient outcomes. But convincing the wider oncology ...
Plus: The startups landing spacecraft on the Moon, re-engineering immune cells to fight cancer, why you should warm up your ...
Combination treatment with nivolumab and cabozantinib provides long-term benefits over sunitinib in patients with advanced RCC, according to final results from the CheckMate 9ER trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback